Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-07 · accession 0001209191-22-007864 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2022-02-08 | 2022-02-07 | DLB | TEVANIAN AVADIS | Dir | S - Sale | $75.31 | -1,331 | 51.9K | -3% | -$100.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-07 | S | D | 1,331 | $75.31 | 51,891 | I By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996 | — | — |